PT - JOURNAL ARTICLE AU - Henry N. Nguyen AU - Bruce A. Rasmussen AU - David C. Perry TI - Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography AID - 10.1124/jpet.103.056408 DP - 2003 Dec 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 1090--1097 VI - 307 IP - 3 4099 - http://jpet.aspetjournals.org/content/307/3/1090.short 4100 - http://jpet.aspetjournals.org/content/307/3/1090.full SO - J Pharmacol Exp Ther2003 Dec 01; 307 AB - Subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) are differentially sensitive to up-regulation by chronic nicotine exposure in vitro. To determine whether this occurs in animals, rats were implanted with minipumps containing saline ± nicotine (6.0 mg/kg/rat/day) for 14 days. Autoradiography with [125I]epibatidine using 3-(2(S)-azetidinylmethoxy)pyridine dihydrochloride (A-85380) or cytisine as selective competitors allowed quantitative measurement in 33 regions of 3 families of nAChR binding, with properties of α4β2, α3β4, and α3/α6β2. Chronic nicotine exposure caused increases of 20 to 100% for α4β2-like binding in most regions surveyed. However, binding to this subtype was not increased in some regions, including habenulopeduncular structures, certain thalamic nuclei, and several brainstem regions. In 9 of 33 regions, including catecholaminergic areas and visual structures, α3/α6β2-like binding represented >10% of total binding. Binding to this subtype was up-regulated by nicotine in only two of these nine regions: the nucleus accumbens and superior colliculus. α3β4-Like binding represented >10% of total in 15 of the 33 regions surveyed. Binding to this subtype was increased by nicotine in only 1 of these 15 regions, and actually decreased in subiculum and cerebellum. These studies yielded two principal findings. First, chronic nicotine exposure selectively up-regulates α4β2-like binding, with relatively little effect on α3/α6β2-like and α3β4-like binding in vivo. Second, up-regulation by chronic nicotine exposure shows considerable regional variation. Differential subtype sensitivity to chronic nicotine exposure may contribute to altered pharmacological response in individuals who smoke or use nicotine replacement therapy. The American Society for Pharmacology and Experimental Therapeutics